Kelly J Henrickson, MD

CHILDREN'S HOSPITAL OF WISCONSIN SINCE 1990
Professor

Office Locations

8915 W. Connell Ave
Milwaukee, WI 53226
(414) 337-7070

Overview

Dr. Henrickson cares for children and teaches residents and fellows at the Children’s Hospital of Wisconsin and the Medical College of Wisconsin. He is director of the Midwest Respiratory Virus Program (MRVP) and director of the Respiratory Virus molecular diagnostic laboratory. Dr. Henrickson is founder and past Chairman of the Board of Science officer of Prodesse, Inc. now part of Genprobe Inc. Dr. Henrickson is a voting member of the Microbiology Devices Panel of the Medical Devices Advisory Committee, CDRH, Food and Drug Administration (FDA). He also is a past member of the Wisconsin Biotech Association’s Board of Directors (2001-2004). Dr. Henrickson serves as a reviewer for numerous publications including; Journal of clinical Virology, Immunology and Infectious Diseases, Clinical Infectious Diseases, Journal of Infectious Diseases, Pediatric Infectious Diseases Journal, Pediatric Hematology and Oncology, Emerging Infectious Diseases, and Clinical and Diagnostic Laboratory Immunology.

In addition to his academic and clinical work, Dr. Henrickson has served as an editor and reviewer in various national and international capacities, including work for NIH/NIAID, CDC and VA Study Sections on Experimental Virology and molecular diagnostics (2007-2009). Most recently he has served on special emphasis panels on SARS and bioterrorism agents (2004, 2005) and pandemic influenza vaccines and diagnostics (2006-2008) and non-pharmaceutical interventions for Pandemic Influenza (2006), Biodefense Therapeutic (2008) and molecular sample collection technologies (2009). He recently reviewed the U.S. military infectious disease program (USAMRIID, 2003) and was on the scientific advisory board for the “International Symposium on Respiratory viral infections” (2005). He has lectured extensively (nationally and internationally) on an array of topics but most specifically on viral respiratory disease, molecular diagnostics and the epidemiology and natural history of influenza and pandemic disease. In addition, he has published over 141 articles, abstracts, and book chapters, primarily on respiratory viruses.

Certifications
Pediatric Infectious Diseases
Areas of Interest
  • Molecular diagnostics
  • Viral respiratory disease
  • Infectious diseases

Education & Awards

Education
  • 1984, University of Washington School of Medicine, MD
Residency
  • 1987, Strong Memorial Hosp (Rochester, NY)
Fellowship
  • 1990, St Jude Childrens Research Hospital (Memphis, TN)

Research & Publications

Research

At this point in his career, Dr. Henrickson has received 71 grants and awards totaling over $17 million in funds. He has been a principal research investigator on these projects including studies on molecular evolution, antigenic variation of surface glycoprotiens, epidemiology and natural history of parainfuenza and influenza viruses and the development of rapid molecular diagnostic assays. His most recent awards from the NIAID include working on advances in molecular diagnostics for influenza subtyping (including avian and swine) (2006-2011), bioterrorism agents (2003-2012), and working on multiplex point of care diagnostic assays for community acquired respiratory viruses (2008-2012). Other funded research grants and contracts include a BARDA contract for evaluating influenza diagnostic assays (2010-2015) and the development of molecular diagnostic assays for community acquired pneumonia and sepsis including influenza virus type A and B. Dr. Henrickson’s most recent work includes close collaborations with the NIH to describe the epidemiology and evolution of the 2009 pandemic H1N1 virus and extending the knowledge base for paramyxovirus genomic data (1st author on white paper-2010). He has earned U.S. and Australian patents on human parainfluenza Virus I, 2, and 3 assays, and on the Hexaplex assay (multiplex asymetric RT-PCR) for rapid viral diagnosis. He and his laboratory have developed more than a dozen multiplex molecular diagnostic assays to bioterrorism agents, viruses and respiratory pathogens.